Scabies Market Summary
Scabies Market Insights & Epidemiology Forecast
- The Scabies Market is expected to strengthen as awareness of the disease increases, and more effective interventions are being developed.
- The leading Scabies Companies such as Cipher Pharmaceuticals Inc., Mayne Pharma International Pty Ltd, Saptalis Pharmaceuticals LLC, Encube Ethicals Pvt. Ltd., ParaPRO LLC, Dr. Reddy's Laboratories Limited, Mylan Inc., and others.
Request for Unlocking the Sample Page of the "Scabies Treatment Market"
Key Factors Driving the Scabies Market Growth
-
Rising Global Prevalence of Scabies
Increasing incidence of scabies, particularly in low- and middle-income countries, crowded living conditions, and institutional settings such as nursing homes and refugee camps, is significantly driving market demand.
-
Growing Awareness and Improved Diagnosis
Enhanced awareness among healthcare professionals and patients, along with better diagnostic practices, is leading to higher diagnosis and treatment rates.
-
Unmet Medical Needs and Treatment Resistance
Limitations of existing therapies, including treatment failures and emerging resistance to commonly used agents like permethrin, are creating demand for more effective and novel treatment options.
-
Advancements in Therapeutic Development
Ongoing research and development focused on next-generation topical and oral therapies, including improved formulations and combination treatments, are fueling market growth.
-
Expansion of Healthcare Access
Improving healthcare infrastructure and access to dermatological care in emerging markets are enabling earlier diagnosis and broader treatment adoption.
-
Pipeline Momentum and Regulatory Support
A growing clinical pipeline, coupled with regulatory incentives for infectious and neglected diseases, is accelerating the introduction of new therapies.
-
Pediatric and Institutional Treatment Demand
High disease burden among children and in long-term care facilities is increasing the demand for safe, easy-to-administer, and scalable treatment options.
DelveInsight's "Scabies Market Insights, Epidemiology, and Market Forecast-2034" report delivers an in-depth understanding of the Scabies, historical and forecasted epidemiology as well as the Scabies market trends in the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom) and Japan.
The Scabies Treatment Market Report provides current treatment practices, emerging drugs, Scabies market share of the individual therapies, current and forecasted Scabies market Size from 2020 to 2034 segmented by seven major markets. The Report also covers current Scabies treatment practice/algorithm, market drivers, market barriers and unmet medical needs to curate the best of the opportunities and assesses the underlying potential of the Scabies market.
Scope of the Scabies Market | |
|
Study Period |
2020 to 2034 |
|
Forecast Period |
2024-2034 |
|
Geographies Covered |
|
|
Scabies Market |
|
|
Scabies Market Size | |
|
Scabies Companies |
|
Scabies Disease Understanding and Treatment Algorithm
DelveInsight’s Scabies market report gives a thorough understanding of Scabies by including details such as disease definition, symptoms, causes, pathophysiology, diagnosis, and treatment. Scabies is a highly contagious parasitic skin infestation caused by the microscopic mite Sarcoptes scabiei var. hominis. The condition affects people of all ages worldwide and is particularly common in crowded living environments, low-resource settings, and institutional facilities such as nursing homes, prisons, and refugee camps. Scabies is transmitted primarily through prolonged skin-to-skin contact, making household members, sexual partners, and caregivers especially vulnerable. Less commonly, transmission can occur through shared clothing, bedding, or towels, particularly in cases of crusted (Norwegian) scabies, which involves a high mite burden.
Scabies Diagnosis
Scabies diagnosis is primarily based on clinical evaluation, supported by patient history and characteristic symptoms such as intense nocturnal itching, burrows, papules, nodules, and crusted lesions in typical body sites including the interdigital spaces, wrists, axillae, waistline, and genital area. Confirmation may be achieved through microscopic examination of skin scrapings to identify mites, eggs, or fecal pellets, although this method has limited sensitivity. This segment of the report covers the detailed diagnostic methods or tests for Scabies.
Scabies Treatment
Scabies treatment focuses on eradicating the Sarcoptes scabiei mite, relieving symptoms, and preventing reinfestation, typically through the use of topical or oral antiparasitic therapies. First-line treatment commonly includes topical permethrin 5% cream, which is widely used due to its high efficacy and favorable safety profile, while oral ivermectin is often prescribed in cases of crusted scabies, treatment resistance, outbreaks, or when topical therapy is impractical. Successful management also requires treating close contacts simultaneously, laundering clothing and bedding in hot water, and implementing environmental control measures to reduce transmission. It covers the details of conventional and current medical therapies available in the Scabies market for the treatment of the condition. It also provides Scabies treatment algorithms and guidelines in the United States, Europe, and Japan.
Scabies Epidemiology
The Scabies epidemiology section provides insights about the historical and current Scabies patient pool and forecasted trends for individual seven major countries. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and the views of key opinion leaders. This part of the Scabies market report also provides the diagnosed patient pool and their trends along with assumptions undertaken.
Key findings from the Scabies Epidemiological Analysis
The disease epidemiology covered in the report provides historical as well as forecasted Scabies epidemiology scenario in the 7MM covering the United States, EU5 countries (Germany, Spain, Italy, France, and the United Kingdom), and Japan from 2020 to 2034.
Country-Wise- Scabies Epidemiology
The epidemiology segment also provides the Scabies Prevalence Data and findings across the United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan.
Scabies Market Recent Breakthroughs
- In February 2025, Cipher Pharmaceuticals Inc. initiated a clinical study evaluating Natroba® (spinosad) Topical Suspension 0.9% w/w in infants and young children aged 1 month to 3 years and 11 months with an active scabies infestation. The study aims to assess the pharmacokinetics of spinosad and benzyl alcohol following a single, full-body topical application administered during one in-clinic visit in an open-label design. Approximately 50 pediatric participants are expected to be enrolled, with the objective of completing evaluations in around 16 subjects, and PK sampling conducted for up to three hours post-application.
Scabies Drug Analysis
The drug chapter segment of the Scabies treatment market report encloses the detailed analysis of Scabies marketed drugs and late-stage (Phase-III and Phase-II) Scabies pipeline drugs. It also helps to understand the Scabies clinical trial details, expressive pharmacological action, agreements and collaborations, approval and patent details, advantages and disadvantages of each included drug and the latest Scabies news and press releases.
Scabies Marketed Drugs
The Scabies Therapeutics Market Report provides the details of the marketed products/off-label treatments available for Scabies treatment.
Scabies Emerging Drugs
The Scabies Therapeutics Market Report provides the details of the emerging therapies under the late and mid-stage of development for Scabies treatment.
Scabies Market Outlook
The Scabies market outlook of the report helps to build a detailed comprehension of the historic, current, and forecasted Scabies market trends by analyzing the impact of current Scabies therapies on the market, unmet needs, drivers and barriers, and demand for better technology.
This segment gives a thorough detail of Scabies market trend of each marketed drug and late-stage pipeline therapy by evaluating their impact based on the annual cost of therapy, inclusion and exclusion criteria's, mechanism of action, compliance rate, growing need of the market, increasing patient pool, covered patient segment, expected launch year, competition with other therapies, brand value, their impact on the market and view of the key opinion leaders. The calculated Scabies market data are presented with relevant tables and graphs to give a clear view of the market at first sight.
According to DelveInsight, the Scabies Treatment Market in 7MM is expected to witness a major change in the study period 2020-2034.
Key Findings
This section includes a glimpse of the Scabies Treatment Market in 7MM.
The United States Scabies Market Outlook
This section provides the total Scabies market size and market size by therapies in the United States.
EU-5 Countries: Scabies Market Outlook
The total Scabies market size and market size by therapies in Germany, France, Italy, Spain, and the United Kingdom is provided in this section.
Japan Scabies Market Outlook
The total Scabies market size and market size by therapies in Japan is also mentioned.
Scabies Drugs Uptake
This section focuses on the rate of uptake of the potential Scabies drugs recently launched in the Scabies market or expected to get launched in the market during the study period 2020-2034. The analysis covers Scabies market uptake by drugs; patient uptake by therapies; and sales of each drug. Scabies Drugs Uptake helps in understanding the drugs with the most rapid uptake, reasons behind the maximal use of new Scabies drugs, and allow the comparison of the drugs on the basis of Scabies market share and size which again will be useful in investigating factors important in market uptake and in making financial and regulatory decisions.
Scabies Pipeline Development Activities
The Scabies Therapeutics Market Report provides insights into different therapeutic candidates in Phase II, and Phase III stage. It also analyses Scabies Companies involved in developing targeted therapeutics. The Scabies report covers the detailed information of collaborations, acquisition, and merger, licensing, patent details, and other information for Scabies emerging therapies.
Scabies Reimbursement Scenario
Approaching reimbursement proactively can have a positive impact both during the late stages of product development and well after product launch. In a report, we take reimbursement into consideration to identify economically attractive indications and market opportunities. When working with finite resources, the ability to select the markets with the fewest reimbursement barriers can be a critical business and price strategy.
Latest KOL- Views on Scabies
To keep up with current Scabies market trends, we take KOLs and SMEs ' opinion working in the Scabies domain through primary research to fill the data gaps and validate our secondary research. Their opinion helps to understand and validate current and emerging therapies treatment patterns or Scabies market trends. This will support the clients in potential upcoming novel treatment by identifying the overall scenario of the market and the unmet needs.
Scabies Competitive Intelligence Analysis
We perform Competitive and Market Intelligence analysis of the Scabies Market by using various Competitive Intelligence tools that include - SWOT analysis, PESTLE analysis, Porter's five forces, BCG Matrix, Market entry strategies etc. The inclusion of the analysis entirely depends upon the data availability.
Scabies Market Report Scope
- The Scabies Therapeutics Market Report covers the descriptive overview, explaining its causes, signs and symptoms, pathophysiology, diagnosis and currently available therapies
- Comprehensive insight has been provided into the Scabies epidemiology and treatment in the 7MM
- Additionally, an all-inclusive account of both the current and emerging therapies for Scabies is provided, along with the assessment of new therapies, which will have an impact on the current treatment landscape
- A detailed review of the Scabies Treatment Market, historical and forecasted is included in the report, covering drug outreach in the 7MM
- The Scabies Therapeutics Market Report provides an edge while developing business strategies, by understanding trends shaping and driving the global Scabies drugs market
Scabies Market Report Highlights
- In the coming years, the Scabies Treatment Market is set to change due to the rising awareness of the disease, and incremental healthcare spending across the world; which would expand the size of the market to enable the drug Scabies manufacturers to penetrate more into the market
- The Scabies Companies and academics are working to assess challenges and seek opportunities that could influence Scabies R&D. The therapies under development are focused on novel approaches to treat/improve the disease condition
- Major Scabies Companies are involved in developing therapies for Scabies. The launch of emerging therapies will significantly impact the Scabies market
- A better understanding of disease pathogenesis will also contribute to the development of novel therapeutics for Scabies
- Our in-depth analysis of the Scabies Pipeline assets across different stages of development (Phase III and Phase II), different emerging trends and comparative analysis of pipeline products with detailed clinical profiles, key cross-competition, launch date along with product development activities will support the clients in the decision-making process regarding their therapeutic portfolio by identifying the overall scenario of the research and development activities
Scabies Market Report Insights
- Scabies Patient Population
- Therapeutic Approaches
- Scabies Pipeline Analysis
- Scabies Market Size and Trends
- Scabies Drugs Market Opportunities
- Impact of upcoming Scabies Therapies
Scabies Market Report Key Strengths
- 11 Years Scabies Market Forecast
- 7MM Coverage
- Scabies Epidemiology Segmentation
- Key Cross Competition
- Highly Analyzed Scabies Drugs Market
- Scabies Drugs Uptake
Scabies Market Report Assessment
- Current Scabies Treatment Practices
- Scabies Unmet Needs
- Scabies Pipeline Drugs Profiles
- Scabies Drugs Market Attractiveness
- Scabies Market Drivers and Barriers
Key Questions Answered in the Scabies Market Report
Scabies Market Insights:
- What was the Scabies drugs market share (%) distribution in 2020 and how it would look like in 2034?
- What would be the Scabies Market Size as well as market size by therapies across the 7MM during the forecast period (2024-2034)?
- What are the key findings pertaining to the market across 7MM and which country will have the largest Scabies market size during the forecast period (2024-2034)?
- At what CAGR, the Scabies market is expected to grow by 7MM during the forecast period (2024-2034)?
- What would be the Scabies market outlook across the 7MM during the forecast period (2024-2034)?
- What would be the Scabies market growth till 2034, and what will be the resultant market Size in the year 2034?
- How would the unmet needs affect the market dynamics and subsequent analysis of the associated trends?
Scabies Epidemiology Insights:
- What are the disease risk, burden, and regional/ethnic differences of Scabies?
- What are the key factors driving the epidemiology trend for seven major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK), and Japan?
- What is the historical Scabies patient pool in seven major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK), and Japan?
- What would be the forecasted patient pool of Scabies in seven major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK), and Japan?
- Where will be the growth opportunities in the 7MM with respect to the patient population pertaining to Scabies?
- Out of all 7MM countries, which country would have the highest prevalent population of Scabies during the forecast period (2024-2034)?
- At what CAGR the patient population is expected to grow in 7MM during the forecast period (2024-2034)?
Current Scabies Treatment Scenario, Marketed Drugs and Emerging Therapies:
- What are the current options for the Scabies treatment in addition to the approved therapies?
- What are the current treatment guidelines for the treatment of Scabies in the USA, Europe, and Japan?
- What are the Scabies marketed drugs and their respective Scabies MOA, regulatory milestones, product development activities, advantages, disadvantages, safety and efficacy, etc.?
- How many companies are developing therapies for the treatment of Scabies?
- How many therapies are in-development by each company for Scabies treatment?
- How many are emerging therapies in mid-stage, and late stage of development for Scabies treatment?
- What are the key collaborations (Industry - Industry, Industry - Academia), Mergers and acquisitions, licensing activities related to the Scabies therapies?
- What are the recent novel therapies, targets, Scabies Mechanisms of Action and technologies being developed to overcome the limitation of existing therapies?
- What are the clinical studies going on for Scabies and their status?
- What are the current challenges faced in drug development?
- What are the key designations that have been granted for the Scabies Emerging Therapies?
- What are the global historical and forecasted Scabies Market?
Reasons to Buy the Scabies Market Report
- The Scabies Market Report will help in developing business strategies by understanding trends shaping and driving the Scabies Drugs Market
- To understand the future market competition in the Scabies Drugs Market, and an Insightful review of the key market drivers and barriers
- Organize sales and marketing efforts by identifying the best opportunities for Scabies in the US, Europe (Germany, Spain, Italy, France, and the United Kingdom) and Japan
- Identification of strong upcoming players in the Scabies Drugs Market will help in devising strategies that will help in getting ahead of competitors
- Organize sales and marketing efforts by identifying the best opportunities for the Scabies Drugs Market
- To understand the future market competition in the Scabies Drugs Market
Stay updated with us for Recent Articles @ New DelveInsight Blogs
